University of California San Francisco
Give to UCSF
About 6% of asymptomatic adults have a biomarker for Alzheimer's disease and are already showing very subtle signs of the disease that would not come to light in a standard cognitive test.
Mark Anderson, MD, PhD, a pioneer in diabetes research and professor of medicine at UCSF, has been elected to the National Academy of Sciences — one of the highest honors in American science.
A team at UCSF developed a multitask deep learning framework that can effectively predict Alzheimer’s disease diagnosis, cognitive scores, and future cognitive decline using only baseline MRI and demographics.
Pairing vulnerable, low-income patients with asthma coaches can improve outcomes and may also reduce costs associated with avoidable health care use.
In the last few years, progress has been made in the fight against Alzheimer’s disease with a class of therapies called anti-amyloid antibodies (anti-Aβ). These anti-Aβ therapies, like lecanumab
Jody Baron and Gabi Fragiadakis discover why some people with chronic Hepatitis B are cured after they're taken off of antiviral drugs, despite falling severely ill when the drug regiment stops.
UCSF expert Charles Chiu discusses rising measles cases, extreme contagiousness, and why 95% vaccination rates are vital for community safety.
Joe Bondy-Denomy solves a CRISPR caper: this is how a viral protein stows itself on protein factories in bacteria, and destroys a CRISPR protein, designed to kill viruses, while it's being made.
UCSF’s pharmacogenetics program uses DNA testing to personalize prescriptions, reducing side effects and ensuring the right drug and dose for every patient.
Six pairs of UC San Francisco faculty members and their PhD students have been awarded funding through the W. M. Keck Foundation’s inaugural Scholar-Fellow Bridge Initiative, a program designed to
The University of California Board of Regents approved plans for the UCSF Bakar Ear & Hearing Institute, a new, state-of-the-art ear facility at UCSF’s Mission Bay campus, taking the first step to creating one of the world’s leading centers for advancing research and care for hearing and balance disorders.
Multiple clinical trials have shown that GLP-1s are safe and effective for patients with obesity, diabetes and cardiovascular conditions. New evidence shows that the drugs may also protect against neurological diseases, like dementia, Parkinson's, and substance use disorder.
A large team of scientists, found that a single dose of psilocybin created positive changes in the brain and well-being, one hour and one month after administration.
A team of researchers discover how the <i>stentor</i>, an organism made of a single, gigantic cell, learns without a brain.
Epilepsy physicians Jon Kleen and Eddie Chang used high-resolution technology to see how cognition is disrupted in people with epilepsy and predict when it will occur. The new view points the way to being able to fend of these disruptions.
The American Association for the Advancement of Science, one of the world’s largest general scientific societies and publisher of the Science family of journals, named three UCSF faculty to the 2025 class of AAAS Honorary Fellows: Elissa Epel, Geeta Jayant Narlikar, and Donald Emil Ganem (emeritus).
A global team of scientists and clinicians found that a cheap, easy-to-use test for tuberculosis was just as good, if not better, at detecting disease than existing tests, shortening time to a diagnosis from days to just 15 minutes.
Discover how SF became the first city to use doxycycline to drop STI rates by up to 24%. UCSF experts explain the impact of doxy-PEP.
UCSF's Cherry Leung, associate professor of community health systems with the UC San Francisco School of Nursing, researches the gut-brain axis as a potential adjunct therapy for improving adolescent mental health.
Freeze-dried human platelets could be used as a "molecular tourniquet" for brain bleeds in the minutes to hours after a traumatic brain injury, according to a UCSF team led by Shibani Pati. The scientists envision stocking ambulances and EDs with the product.
Rushika M. Perera, the Deborah Cowan Professor and vice chair of the Department of Anatomy, and chief scientific officer of UCSF’s Pancreas Center, shared her insights on pancreatic cancer on April 16 when she presented the 2026 Byers Award Lecture in Basic Science.
In recognition of “National Healthcare Decisions Day,” the “PREPARE for Your Care” program at UC San Francisco is making it easier for clinicians to remind their patients of the importance of planning
UCSF research led to the first type 1 diabetes immunotherapy. Now, scientists are using stem cells and Tregs to find a functional cure.
A policy paper argues that diagnostics are critical to modern medicine, but weak policies and low investment hold back their development and use.
Cardiology experts from UCSF Health presented new research and clinical findings at the American College of Cardiology’s (ACC) Annual Scientific Session and Expo in New Orleans, March 28 to 30. The
A new study by UCSF researchers who mapped the maternal-fetal interface, which is the boundary where the mother's uterus and the developing baby's placenta meet, has yielded some surprising findings with potential public health consequences.
UCSF research shows psychedelics like psilocybin may treat depression, Parkinson’s, and addiction, offering new hope in clinical trials.
Rajiv Sethi, MD, PhD, has been appointed chief of the UCSF Division of Orthopaedic Spine Surgery, one of the nation’s premier spine programs. He has also been named co-director of the UCSF Spine
UCSF researchers are studying how climate change fuels toxic algal blooms, partnering with global and tribal communities to monitor health risks and protect food security.
Researchers discover that the nerve cells that make us uniquely human are also uniquely vulnerable to dying during the waves of inflammation that occur in multiple sclerosis.
